. Pedigree of the family (M373) with proband being a compound heterozygote for two BARD1 variants: an in-frame deletion in exon 4, c.1075_1095del (p.Leu359_Pro365del) and a silent variant in exon 10, c.1977A>G, resulting in the missplicing, r.159_1903del (p.Cys53_Trp635delinsfs*12). Abbreviations: OvCa-ovarian cancer; "→"-proband; (36)-age at diagnosis; ''/''-dead.
In order to determine if identified variants affect BARD1 in cis or trans, we conducted RT-PCR experiment using a primer specific for 21bp deletion in exon 4 (c.1075_1095del) and second, spanning exon 10 and 11 junction. Agarose gel electrophoresis revealed a band of expected fragment size (959bp), presented exclusively in proband's sample (marked with an arrow) but not in control cDNAs. Consequently, the band was cut from the gel and sequenced. The Sanger sequencing analysis confirmed that variant c. 
